Ticagrelor-induced thrombotic thrombocytopenic purpura
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000011206
Abstract: Rationale: Ticagrelor, a new type of P2Y12 receptor antagonist, has been highly recommended to be used in acute coronary syndrome by the latest guideline, but its side effects are not well-known. We seek to illustrate… read more here.
Keywords: ticagrelor; thrombotic thrombocytopenic; thrombocytopenic purpura; ticagrelor induced ... See more keywords
Ticagrelor-Induced Complete Heart Block: A Rare Entity
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Pharmacology and Pharmacotherapeutics"
DOI: 10.4103/jpp.jpp_121_19
Abstract: Ticagrelor, a purinergic P2Y12 receptor blocker, is a potent platelet antagonist and an important component in the treatment for acute coronary syndromes identified to have a potential risk to cause bradyarrhythmias. Here, we report the… read more here.
Keywords: ticagrelor; complete heart; block; ticagrelor induced ... See more keywords